T. Avčin

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Tadej Avcin, T. Avcin, T Avcin, Tadej Avčin, Tadej Avčin, T Avčin, T. Avčin
Publication record
282 papers · 8,684 citations · H-index 45

PAPERS

Challenges in the transition of care for rare connective tissue diseases: results from the 2023 ERN ReCONNET Transition of Care Task Force survey
20253 citationsauthor #13
International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders
20253 citationsauthor #10
Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis
20240 citationsauthor #11
Serological response after COVID-19 infection compared to vaccination against COVID-19 in children with autoimmune rheumatic diseases
20242 citationsauthor #3
Systemic autoinflammatory manifestations in patients with spondyloarthritis.
20243 citationsauthor #17
Long-term follow-up of 109 children with juvenile idiopathic oligoarthritis after first intra-articular corticosteroid injection
20246 citationsauthor #5
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research
20243 citationsauthor #4
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network
20244 citationsauthor #27
Increased Frequency of Circulating Activated FOXP3+ Regulatory T Cell Subset in Patients with Chronic Lymphocytic Leukemia Is Associated with the Estimate of the Size of the Tumor Mass, STAT5 Signaling and Disease Course during Follow-Up of Patients on Therapy
20242 citationsauthor #4
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multicriteria Decision Analysis
20244 citationsauthor #5
Shaping the future of pediatric rheumatology
20241 citationsauthor #1
Towards telehealth delivery in pediatric rheumatology practice
20239 citationsauthor #2
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases.
202321 citationsauthor #29
Genomic investigations of unexplained acute hepatitis in children
202398 citationsauthor #304
Points to consider: EULAR–UEMS standards for the training of European rheumatologists
20232 citationsauthor #2
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis.
20238 citationsauthor #12
AB1325 SINGLE CELL MULTIOMIC PROFILING OF DISRUPTED REGULATORY NETWORKS IN COVID19 ASSOCIATED MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
20230 citationsauthor #8
The characteristics of patients with COVID‐19–associated pediatric vasculitis: an international, multicenter study: comment on the article by Batu et al
20230 citationsauthor #2
Alterations in immunophenotype and metabolic profile of mononuclear cells during follow up in children with multisystem inflammatory syndrome (MIS-C)
20234 citationsauthor #9
Chapter 22 Multisystem inflammatory syndrome in children
20230 citationsauthor #2
2023 ACR/EULAR antiphospholipid syndrome classification criteria
2023310 citationsauthor #12
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination
20236 citationsauthor #3
OA39 Development of a Childhood Lupus Low Disease Activity State definition: recommendations from the International Childhood Lupus Treat-to-Target Task Force
20230 citationsauthor #5
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS).
202322 citationsauthor #5
Case report: Pneumocystis jirovecii pneumonia in a severe case of Aicardi–Goutières syndrome with an IFIH1 gain-of-function mutation mimicking combined immunodeficiency
20239 citationsauthor #8
A clinical perspective on imaging in juvenile idiopathic arthritis
20239 citationsauthor #5
Letter to the editor: Response to "The Characteristics of Patients With COVID-19-Associated Pediatric Vasculitis: An International, Multicenter Study " by Batu et al.
20230 citationsauthor #2
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force
202335 citationsauthor #5
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.
20236 citationsauthor #8
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
2023305 citationsauthor #12
Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis
20235 citationsauthor #18
Adeno-associated virus 2 infection in children with non-A–E hepatitis
202326 citationsauthor #289
Biobanking and consenting to research: a qualitative thematic analysis of young people’s perspectives in the North East of England
20233 citationsauthor #255
Comprehensive Care and Education Can Improve Nutritional and Growth Outcomes in Children with Persistent Cow’s Milk, Egg, or Peanut Allergies: A Five-Year Follow-Up Study of Nutritional Status
20234 citationsauthor #7
POS0139 DIFFUSE JUVENILE SYSTEMIC SCLEROSIS PATIENTS SHOW DISTINCT ORGAN INVOLVEMENT, ANTIBODY PATTERN AND HAVE SIGNIFICANTLY MORE SEVERE DISEASE IN THE LARGEST JSSC COHORT OF THE WORLD. RESULTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT
20230 citationsauthor #21
High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe.
202215 citationsauthor #24
POS1293 TEN-YEAR EFFICACY DATA FROM THE CLIPPER STUDIES: OPEN-LABEL, LONG-TERM ETANERCEPT TREATMENT IN CHILDREN AND YOUNG ADULTS WITH EXTENDED OLIGOARTICULAR, ENTHESITIS-RELATED, OR PSORIATIC JUVENILE IDIOPATHIC ARTHRITIS
20220 citationsauthor #11
POS0169 OPEN-LABEL, LONG-TERM (10-YEAR) STUDY OF THE SAFETY OF ETANERCEPT IN CHILDREN AND YOUNG ADULTS WITH EXTENDED OLIGOARTICULAR, ENTHESITIS-RELATED, OR PSORIATIC JUVENILE IDIOPATHIC ARTHRITIS
20220 citationsauthor #11
Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
20220 citationsauthor #7
Autoimmune and autoinflammatory manifestations in inborn errors of immunity
20223 citationsauthor #3
Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021
202212 citationsauthor #2
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
202223 citationsauthor #7
AB1144 COGNITIVE AND PSYCHOSOCIAL OUTCOME IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME FOLLOWING SARS-CoV-2 INFECTION
20221 citationsauthor #7
OP0219 HIGH INCIDENCE OF MIS-C AND OTHER AUTOIMMUNE DISEASES AFTER SARS-COV-2 INFECTION COMPARED TO COVID-19 VACCINATION IN PEDIATRIC POPULATION FROM SOUTH CENTRAL EUROPE
20221 citationsauthor #11
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.
20227 citationsauthor #3
DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling
202227 citationsauthor #26
A Rose Amongst the Thorns: the Mission of the J Project in a Conflictual World
20224 citationsauthor #4
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study.
202243 citationsauthor #12
Addressing mental health issues in immunocompromised adolescents with chronic diseases during the COVID-19 pandemic
20221 citationsauthor #1
Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort
20225 citationsauthor #17
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force
202218 citationsauthor #19
The expansion of human T-bethighCD21low B cells is T cell dependent
2021107 citationsauthor #33
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis
202164 citationsauthor #9
Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma
20216 citationsauthor #14
POS0079 PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS HAVE A DISTINCT PATTERN OF ORGAN INVOLVEMENT.RESULTS FROM THE JUVENILE SYSTEMIC SCLEROSIS INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM
20211 citationsauthor #18
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
202140 citationsauthor #7
POS0072 COMPREHENSIVE IMMUNE PROFILING OF 20 CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME
20211 citationsauthor #7
POS1318 A NATIONWIDE COHORT STUDY ON CLINICAL AND LABORATORY MANIFESTATIONS IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME (MIS-C)
20211 citationsauthor #8
Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort
202121 citationsauthor #14
Editorial: Therapeutic Implications for Pregnant Women With Systemic Autoimmune Diseases and Their Children
20210 citationsauthor #4
JLS Elicitation Extended data.pdf
20211 citationsauthor #15
OP0074 A FRAMEWORK OF POTENTIAL INTERVENTIONS TO ACCELERATE GENDER-EQUITABLE CAREER ADVANCEMENT IN ACADEMIC RHEUMATOLOGY
20211 citationsauthor #19
Prophylactic Anticoagulation Therapy: Comment on the Article by Henderson et al
20212 citationsauthor #4
NATIONAL RECOMMENDATIONS FOR ANTICOAGULANT THROMBOPROPHYLAXIS IN CHILDREN AND ADOLESCENTS WITH SARS-COV-2 INFECTION
20210 citationsauthor #3
Autoantibodies and Kidney Diseases
20210 citationsauthor #4
DNASE1L3 Deficiency, New Phenotypes and Evidence for a Transient Type I Interferon Signaling
20211 citationsauthor #25
Case Report: Necrotizing Stomatitis as a Manifestation of COVID-19-Associated Vasculopathy
20212 citationsauthor #7
POS1304 JUVENILE SYSTEMIC SCLEROSIS (JSSC) PATIENTS WITH OVERLAP CHARACTERISTICS DO NOT HAVE MILD DISEASE. RESULTS FROM THE JSSC INCEPTION COHORT. WWW.JUVENILESCLERODERMA.COM
20211 citationsauthor #18
The Clinical and Genetic Spectrum of 82 Patients With RAG Deficiency Including a c.256_257delAA Founder Variant in Slavic Countries
202017 citationsauthor #14
Proceedings of the 26th European Paediatric Rheumatology Congress: part 1
20204 citationsauthor #29
European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.
202024 citationsauthor #5
THU0580 EULAR TASK FORCE ON GENDER EQUITY IN ACADEMIC RHEUMATOLOGY: PRELIMINARY SURVEY FINDINGS
20206 citationsauthor #19
PIK3AP1 and SPON2 Genes Are Differentially Methylated in Patients With Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) Syndrome
202015 citationsauthor #8
Consensus-based recommendations for the management of juvenile systemic sclerosis.
202037 citationsauthor #5
Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis
202018 citationsauthor #14
Chronic non-bacterial osteomyelitis: a retrospective international study on clinical manifestations and response to treatment.
202016 citationsauthor #13
2019 EULAR points to consider for the assessment of competences in rheumatology specialty training
202013 citationsauthor #4
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee
202032 citationsauthor #98
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
202075 citationsauthor #5
Pediatric APS: State of the Art
202028 citationsauthor #2
Flow Cytometric Determination of Actin Polymerization in Peripheral Blood Leukocytes Effectively Discriminate Patients With Homozygous Mutation in ARPC1B From Asymptomatic Carriers and Normal Controls
201914 citationsauthor #5
Vaccination coverage in children with rheumatic diseases.
201930 citationsauthor #5
Extraintestinal Manifestations of Inflammatory Bowel Disease
20190 citationsauthor #3
THU0666 SERIOUS/AT LEAST MODERATE INFECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS ON SYNTHETIC AND BIOLOGIC DRUGS FROM THE PHARMACHILD REGISTRY
20191 citationsauthor #11
Consensus-based recommendations for the management of juvenile localised scleroderma
2019100 citationsauthor #5
Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
201928 citationsauthor #6
Vaccine immune response, autoimmunity and morbidity after neonatal blood exchange transfusion.
20191 citationsauthor #6
Primary immunodeficiencies in Central and Eastern Europe—the power of networking Report on the activity of the Jeffrey Modell Foundation Centers Network in Central and Eastern Europe
20196 citationsauthor #19
SAT0524B THE HETEROGENEITY OF JUVENILE PSORIATIC ARTHRITIS: EVIDENCE FROM A LARGE MULTINATIONAL COHORT
20190 citationsauthor #6
STAT signaling as a marker of SLE disease severity and implications for clinical therapy.
201922 citationsauthor #4
SAT0479 UPDATE FROM THE JUVENILE SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM
20191 citationsauthor #13
The European network for care of children with paediatric rheumatic diseases: care across borders.
201918 citationsauthor #3
Recurrent Fulminant Myocarditis Repeatedly Treated with Ecmo in a Child
20191 citationsauthor #16
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
2019261 citationsauthor #6
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood‐Onset Systemic Lupus Erythematosus
201918 citationsauthor #14
Altered Homeostasis of Regulatory T Lymphocytes and Differential Regulation of STAT1/STAT5 in CD4+ T Lymphocytes in Childhood-onset Systemic Lupus Erythematosus
20194 citationsauthor #3
SAT0478 AFTER 24 MONTHS OBSERVATION PERIOD THE PATIENTS RELATED OUTCOMES IMPROVE SIGNIFICANTLY IN THE JUVENILE SCLERODERMA INCEPTIONS COHORT. WWW.JUVENILE-SCLERODERMA.COM
20190 citationsauthor #7
AB0967 IS THERE A DIFFERENCE IN PRESENTATION OF FEMALE AND MALE PATIENTS WITH JUVENILE SYSTEMIC SCLERODERMA. AN UPDATE FROM THE JUVENILE SYSTEMIC SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM
20190 citationsauthor #13
Undifferentiated connective tissue disease: state of the art on clinical practice guidelines
201945 citationsauthor #5
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
2018334 citationsauthor #10

TIMELINE

1997 244 citations

2001 109 citations

2002 104 citations

2003 28 citations

2004 36 citations

2005 59 citations

2006 200 citations

2007 142 citations

2008 405 citations

2009 230 citations

2010 135 citations

2011 250 citations

2012 431 citations

2013 92 citations

2014 539 citations

2015 254 citations

2016 1,132 citations

2017 775 citations

2018 1,353 citations

2019 550 citations

2020 285 citations

2021 249 citations

2022 160 citations

2023 882 citations

2024 25 citations

2025 6 citations

Unknown 0 citations

T. Avčin

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT